Your browser doesn't support javascript.
loading
Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis.
Li, Nianyi; Lin, Pei; Zuo, Zhuang; You, M James; Shuai, Wen; Orlowski, Robert; Manasanch, Elisabet E; Li, Shaoying; Xu, Jie; Garces, Sofia; Jelloul, Fatima Zahra; Tang, Zhenya; Wang, Wei; Medeiros, L Jeffrey; Yin, C Cameron.
Affiliation
  • Li N; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Texas, Houston, USA.
  • Lin P; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Texas, Houston, USA.
  • Zuo Z; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Texas, Houston, USA.
  • You MJ; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Texas, Houston, USA.
  • Shuai W; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Texas, Houston, USA.
  • Orlowski R; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Texas, Houston, USA.
  • Manasanch EE; Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Texas, Houston, USA.
  • Li S; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Texas, Houston, USA.
  • Xu J; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Texas, Houston, USA.
  • Garces S; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Texas, Houston, USA.
  • Jelloul FZ; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Texas, Houston, USA.
  • Tang Z; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Texas, Houston, USA.
  • Wang W; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Texas, Houston, USA.
  • Medeiros LJ; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Texas, Houston, USA.
  • Yin CC; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Texas, Houston, USA.
Cancer Med ; 12(13): 14293-14304, 2023 07.
Article in En | MEDLINE | ID: mdl-37212518
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Hematopoietic Stem Cell Transplantation / Multiple Myeloma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Med Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Hematopoietic Stem Cell Transplantation / Multiple Myeloma Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Med Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos